Xenon Pharmaceuticals XENE Q1 2026 Earnings Narrowerthanexpected loss highlights operational progress SPFI Q1 2026 Earnings EPS Misses Estimates Stage Set for Cautious Outlook LNTH Q1 2026 Earnings Strong EPS Beat Drives Shares Higher TSAT Q1 2026 Earnings Significant EPS Miss Amidst Strategic Transition Stock Rises IVR Q1 2026 Earnings Slight EPS Miss Amid Stable Operating Environment BNR Q3 2022 Earnings Narrower Loss Surprises as Revenue Remains Undisclosed Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue SION Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment HAS Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Response Nomura Holdings Q1 2026 Earnings Earnings Miss Weighs on Investor Sentiment ADEA Q1 2026 Earnings EPS Beats Estimates Stock Up 19 PHAR Q1 2026 Earnings EPS Misses Expectations by Wide Margin Stock Declines FRHC Q1 2026 Earnings Robust EPS of 125 Drives Stock Higher